UNSPSC 51151626: Camylofin

This classification denotes a parasympatholytic with the molecular formula C19H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 340B6Q764V, chemically known as phenyldiethylaminoethyl-1-aminoacetic acid, isopentyl ester but generally known as camylofin, which bears US NIH Compound Identifier 5902. Camylofin most often comes in base and hydrochloride forms. European Medicines Agency schedules Camylofin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06068MIG.

UNSPSC 51151626 Camylofin (Commodity) describes a pharmaceutical antispasmodic agent, though state and local procurement activity under this code shows a substantial mismatch: recent solicitations tag the code to naloxone and drug deactivation systems, which fall outside the nominal scope of the commodity itself. State and local governments purchasing under this code designation are acquiring opioid-overdose reversal agents and related harm-reduction equipment rather than gastrointestinal antispasmodic medications. Issuing bodies include county health departments and public health agencies focused on emergency response and community health support.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. Bidders must provide unit costs, comply with E-Verify and drug-free workplace certification, maintain specified insurance coverages, and accept a three-month probationary termination clause. The contract carries a two-year initial term with one-year renewal option and was potentially funded through FEMA, introducing compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. The code shows limited recent activity under its stated pharmaceutical classification, suggesting either categorization error in the procurement system or narrow application to this particular opioid-crisis-response use case.